首页 > 最新文献

Womens Health Issues最新文献

英文 中文
Effects of High-Intensity Focused Electromagnetic Therapy (HIFEM) With Pelvic Floor Muscle Training in Mothers Living With Incontinence: A Pilot for a Randomized Controlled Trial. 高强度聚焦电磁疗法(HIFEM)与盆底肌肉训练对失禁母亲的影响:一项随机对照试验的试点研究
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-24 DOI: 10.1016/j.whi.2025.12.002
Wei See Chan, Wing Tung Chow, Yan Tung Poon, Christy S L Tsang, Henry H L Yuen, Edith W Y Lui, Yuen Ting Wong, William W N Tsang

Objective: This pilot study aimed to evaluate the feasibility of a randomized controlled trial comparing high-intensity focused electromagnetic therapy (HIFEM) combined with pelvic floor muscle training (PFMT) versus PFMT alone for improving urine leakage and quality of life in primiparous and multiparous women with stress urinary incontinence (SUI).

Methods: A single-blinded, pilot randomized controlled trial was conducted with primipara and multipara women aged 30 or older who were experiencing symptoms of SUI. Participants were divided into two groups: the experimental group received both HIFEM and PFMT, while the control group received sham HIFEM and PFMT. Treatments were administered weekly for 6 weeks. Feasibility was evaluated in terms of recruitment, retention, adherence, acceptability, safety, blinding integrity, and the practicality of data collection. Urine leakage/bladder health evaluations included the 1-hour pad test, the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), and sonography to measure the vertical movement of the bladder neck, conducted at baseline and after the intervention. One-way repeated measures analysis of covariance was used to compare outcomes between the two groups.

Results: Forty participants were randomly assigned to two groups (n = 20 each). This pilot confirmed the study's feasibility and operational robustness. There were no significant interaction effects between time and group for any measures. However, within-group analysis showed significant improvement in the 1-hour pad test in the experimental group (p = .049) and notable improvements in ICIQ-UI SF scores and sonographic measurements of bladder neck movement in both groups.

Conclusion: These findings support progression to a definitive trial: both interventions improved quality of life and bladder control, and the combination of HIFEM and PFMT significantly reduced urine leakage in the experimental group. Larger, longer-term studies are needed to confirm these results and assess durability. This study was retrospectively registered at ClinicalTrials.gov on 9 October 2024 (Registration ID: NCT06638489).

目的:本初步研究旨在评估一项随机对照试验的可行性,比较高强度聚焦电磁治疗(HIFEM)联合盆底肌训练(PFMT)与单独PFMT在改善初产和多产应激性尿失禁(SUI)妇女尿漏和生活质量方面的效果。方法:对30岁及以上出现SUI症状的初产妇和多产妇进行单盲、随机对照试验。参与者分为两组:实验组同时接受HIFEM和PFMT治疗,对照组接受假HIFEM和PFMT治疗。治疗每周一次,共6周。可行性评估包括招募、保留、依从性、可接受性、安全性、盲法完整性和数据收集的实用性。尿漏/膀胱健康评估包括1小时尿垫试验、国际尿失禁咨询问卷-尿失禁短表(ICIQ-UI SF),以及在基线和干预后进行的超声检查,以测量膀胱颈部的垂直运动。采用单因素重复测量协方差分析比较两组结果。结果:40名参与者随机分为两组(每组20人)。该试验证实了该研究的可行性和操作稳健性。对于任何测量,时间和组之间没有显著的相互作用效应。然而,组内分析显示实验组1小时尿垫试验有显著改善(p = 0.049),两组ICIQ-UI SF评分和膀胱颈部运动超声测量均有显著改善。结论:这些发现支持了一项决定性试验的进展:两种干预措施都改善了生活质量和膀胱控制,HIFEM和PFMT联合使用显著减少了实验组的尿漏。需要更大规模、更长期的研究来证实这些结果并评估其耐久性。该研究于2024年10月9日在ClinicalTrials.gov上回顾性注册(注册ID: NCT06638489)。
{"title":"Effects of High-Intensity Focused Electromagnetic Therapy (HIFEM) With Pelvic Floor Muscle Training in Mothers Living With Incontinence: A Pilot for a Randomized Controlled Trial.","authors":"Wei See Chan, Wing Tung Chow, Yan Tung Poon, Christy S L Tsang, Henry H L Yuen, Edith W Y Lui, Yuen Ting Wong, William W N Tsang","doi":"10.1016/j.whi.2025.12.002","DOIUrl":"https://doi.org/10.1016/j.whi.2025.12.002","url":null,"abstract":"<p><strong>Objective: </strong>This pilot study aimed to evaluate the feasibility of a randomized controlled trial comparing high-intensity focused electromagnetic therapy (HIFEM) combined with pelvic floor muscle training (PFMT) versus PFMT alone for improving urine leakage and quality of life in primiparous and multiparous women with stress urinary incontinence (SUI).</p><p><strong>Methods: </strong>A single-blinded, pilot randomized controlled trial was conducted with primipara and multipara women aged 30 or older who were experiencing symptoms of SUI. Participants were divided into two groups: the experimental group received both HIFEM and PFMT, while the control group received sham HIFEM and PFMT. Treatments were administered weekly for 6 weeks. Feasibility was evaluated in terms of recruitment, retention, adherence, acceptability, safety, blinding integrity, and the practicality of data collection. Urine leakage/bladder health evaluations included the 1-hour pad test, the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), and sonography to measure the vertical movement of the bladder neck, conducted at baseline and after the intervention. One-way repeated measures analysis of covariance was used to compare outcomes between the two groups.</p><p><strong>Results: </strong>Forty participants were randomly assigned to two groups (n = 20 each). This pilot confirmed the study's feasibility and operational robustness. There were no significant interaction effects between time and group for any measures. However, within-group analysis showed significant improvement in the 1-hour pad test in the experimental group (p = .049) and notable improvements in ICIQ-UI SF scores and sonographic measurements of bladder neck movement in both groups.</p><p><strong>Conclusion: </strong>These findings support progression to a definitive trial: both interventions improved quality of life and bladder control, and the combination of HIFEM and PFMT significantly reduced urine leakage in the experimental group. Larger, longer-term studies are needed to confirm these results and assess durability. This study was retrospectively registered at ClinicalTrials.gov on 9 October 2024 (Registration ID: NCT06638489).</p>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitators and Barriers to Providing Trauma-Informed Abortion Care. 提供创伤知情堕胎护理的促进因素和障碍。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-24 DOI: 10.1016/j.whi.2025.12.001
Diana Marino Nuñez, Kristen Chalmers, Candice Norcott, Danielle Young, Julie Chor

Objectives: Individuals who undergo abortion are up to three times more likely to have experienced prior traumatic events compared with the general reproductive age population, including sexual assault, interpersonal violence, or adverse childhood events. We sought to elicit and understand perceived facilitators and barriers to providing trauma-responsive abortion care among abortion providers.

Methods: We recruited providers from Chicago-area abortion clinics to participate in a 45-minute, semi-structured one-on-one phone or Zoom interview. We used thematic content analysis to analyze data, developing and refining our code directory with iterative readings of the text. We used ATLAS.ti to apply codes, calculate Cohen's kappa scores to ensure inter-rater reliability, and identify major themes in the data.

Results: We interviewed 20 abortion providers: 13 physicians and seven nurse midwives/advanced practice nurses. Half of the respondents expressed feeling confident in their ability to provide trauma-responsive care. Participants identified several facilitators to providing trauma-responsive abortion care at the individual level, including receipt of formal or informal training in trauma-responsive care and years of clinical experience, and at the structural level, accessible in-clinic behavioral health support and sedation. Barriers to providing trauma-responsive abortion care included perceived inadequate training, lack of clinical guidelines to standardize staff practices, and absence of screening protocols to identify individuals with a history of trauma.

Conclusion: Several provider and clinic-level factors influence providers' abilities to provide trauma-responsive abortion care. Greater provider training and standardization of trauma-responsive clinic practices and resources are warranted to enhance abortion care for all patients, including those with a history of trauma(s).

目的:与一般育龄人群相比,接受堕胎的个体经历创伤性事件的可能性高达三倍,包括性侵犯、人际暴力或不良的童年事件。我们试图引出并理解在堕胎提供者中提供创伤反应性堕胎护理的感知促进因素和障碍。方法:我们从芝加哥地区的堕胎诊所招募了提供者,参与了45分钟的半结构化一对一电话或Zoom访谈。我们使用主题内容分析来分析数据,通过反复阅读文本来开发和完善我们的代码目录。我们使用ATLAS。应用代码,计算Cohen的kappa分数以确保评分者之间的可靠性,并确定数据中的主要主题。结果:我们采访了20名堕胎提供者:13名医生和7名护士助产士/高级执业护士。一半的受访者表示对自己提供创伤反应性护理的能力充满信心。与会者确定了在个人层面提供创伤反应性堕胎护理的若干促进因素,包括接受创伤反应性护理方面的正式或非正式培训和多年的临床经验,以及在结构层面提供可获得的门诊行为健康支持和镇静。提供创伤反应性流产护理的障碍包括培训不足,缺乏规范工作人员实践的临床指南,以及缺乏筛查方案来识别有创伤史的个体。结论:几个提供者和临床层面的因素影响提供者提供创伤反应性流产护理的能力。必须加强对提供者的培训和创伤响应临床实践和资源的标准化,以加强对所有患者的堕胎护理,包括那些有创伤史的患者。
{"title":"Facilitators and Barriers to Providing Trauma-Informed Abortion Care.","authors":"Diana Marino Nuñez, Kristen Chalmers, Candice Norcott, Danielle Young, Julie Chor","doi":"10.1016/j.whi.2025.12.001","DOIUrl":"https://doi.org/10.1016/j.whi.2025.12.001","url":null,"abstract":"<p><strong>Objectives: </strong>Individuals who undergo abortion are up to three times more likely to have experienced prior traumatic events compared with the general reproductive age population, including sexual assault, interpersonal violence, or adverse childhood events. We sought to elicit and understand perceived facilitators and barriers to providing trauma-responsive abortion care among abortion providers.</p><p><strong>Methods: </strong>We recruited providers from Chicago-area abortion clinics to participate in a 45-minute, semi-structured one-on-one phone or Zoom interview. We used thematic content analysis to analyze data, developing and refining our code directory with iterative readings of the text. We used ATLAS.ti to apply codes, calculate Cohen's kappa scores to ensure inter-rater reliability, and identify major themes in the data.</p><p><strong>Results: </strong>We interviewed 20 abortion providers: 13 physicians and seven nurse midwives/advanced practice nurses. Half of the respondents expressed feeling confident in their ability to provide trauma-responsive care. Participants identified several facilitators to providing trauma-responsive abortion care at the individual level, including receipt of formal or informal training in trauma-responsive care and years of clinical experience, and at the structural level, accessible in-clinic behavioral health support and sedation. Barriers to providing trauma-responsive abortion care included perceived inadequate training, lack of clinical guidelines to standardize staff practices, and absence of screening protocols to identify individuals with a history of trauma.</p><p><strong>Conclusion: </strong>Several provider and clinic-level factors influence providers' abilities to provide trauma-responsive abortion care. Greater provider training and standardization of trauma-responsive clinic practices and resources are warranted to enhance abortion care for all patients, including those with a history of trauma(s).</p>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of a Multistep Approach to Setting Research Priorities to Improve Women Veterans' Health: Updated VA Women's Health Research Agenda. 设置研究优先事项以改善女性退伍军人健康的多步骤方法的结果:更新的VA女性健康研究议程。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-16 DOI: 10.1016/j.whi.2025.12.004
Adriana Rodriguez, Karissa M Fenwick, Amanda E Borsky, Susan M Frayne, Alison B Hamilton, Elizabeth M Yano

Background: Women veterans are the fastest-growing population of new users within the Department of Veterans Affairs (VA) health care delivery system. Building on the priorities established in the 2011 research agenda, and the research conducted in the intervening years, this paper describes the expert panel priority-setting process and reports on the national research priorities for women's health and health care research in VA.

Methods: We applied content analysis to documents from a conference brainstorming session and then facilitated an expert panel using a modified Delphi process to generate a ranked list of research priorities. Participants ranked each priority on a 5-point Likert scale (1 = not at all impactful; 5 = extremely impactful) and we calculated average descriptive statistics across panelists for each item.

Results: We identified 14 research priorities spanning mental health (4 items), access/rural health (3 items), primary care/prevention (2 items), reproductive health (2 items), other research topics (2 items), and complex chronic conditions, aging, and long-term care (1 item). The pertinence of a life course approach emerged across several research priorities.

Conclusion: Researchers, VA program leaders, other federal agency leaders, and women veterans collectively established updated VA women's health research priorities. The VA Office of Research & Development used the priorities to inform a women's health-focused notice of special interest setting funding priorities for women veterans' research, and the Women's Health Research Network will use them in strategic planning.

背景:女性退伍军人是退伍军人事务部(VA)卫生保健服务系统中增长最快的新用户群体。基于2011年研究议程中确定的优先事项,以及在此期间开展的研究,本文描述了专家小组的优先事项设置过程,并报告了弗吉尼亚州妇女健康和医疗保健研究的国家研究优先事项。方法:我们对会议头脑风暴会议的文件进行内容分析,然后促进专家小组使用改进的德尔菲过程生成研究优先事项排序列表。参与者以5分的李克特量表(1 =完全没有影响;5 =极有影响)对每个优先级进行排名,我们计算了每个项目的平均描述性统计数据。结果:我们确定了14个研究重点,包括心理健康(4个项目)、可及性/农村卫生(3个项目)、初级保健/预防(2个项目)、生殖健康(2个项目)、其他研究课题(2个项目)、复杂慢性病、老龄化和长期护理(1个项目)。生命历程方法的相关性出现在几个研究重点中。结论:研究人员、退伍军人管理局项目负责人、其他联邦机构负责人和女性退伍军人共同建立了最新的退伍军人管理局女性健康研究重点。退伍军人事务部研究与发展办公室利用这些优先事项通知了一份以妇女健康为重点的通知,特别关注为女性退伍军人的研究确定资金优先事项,妇女健康研究网络将在战略规划中使用这些优先事项。
{"title":"Results of a Multistep Approach to Setting Research Priorities to Improve Women Veterans' Health: Updated VA Women's Health Research Agenda.","authors":"Adriana Rodriguez, Karissa M Fenwick, Amanda E Borsky, Susan M Frayne, Alison B Hamilton, Elizabeth M Yano","doi":"10.1016/j.whi.2025.12.004","DOIUrl":"10.1016/j.whi.2025.12.004","url":null,"abstract":"<p><strong>Background: </strong>Women veterans are the fastest-growing population of new users within the Department of Veterans Affairs (VA) health care delivery system. Building on the priorities established in the 2011 research agenda, and the research conducted in the intervening years, this paper describes the expert panel priority-setting process and reports on the national research priorities for women's health and health care research in VA.</p><p><strong>Methods: </strong>We applied content analysis to documents from a conference brainstorming session and then facilitated an expert panel using a modified Delphi process to generate a ranked list of research priorities. Participants ranked each priority on a 5-point Likert scale (1 = not at all impactful; 5 = extremely impactful) and we calculated average descriptive statistics across panelists for each item.</p><p><strong>Results: </strong>We identified 14 research priorities spanning mental health (4 items), access/rural health (3 items), primary care/prevention (2 items), reproductive health (2 items), other research topics (2 items), and complex chronic conditions, aging, and long-term care (1 item). The pertinence of a life course approach emerged across several research priorities.</p><p><strong>Conclusion: </strong>Researchers, VA program leaders, other federal agency leaders, and women veterans collectively established updated VA women's health research priorities. The VA Office of Research & Development used the priorities to inform a women's health-focused notice of special interest setting funding priorities for women veterans' research, and the Women's Health Research Network will use them in strategic planning.</p>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Contributions of Gendered Social Factors to Sex Disparities in Adverse Drug Events. 探讨性别社会因素对药物不良事件性别差异的影响。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-08 DOI: 10.1016/j.whi.2025.12.003
Annika Gompers, Tamara Rushovich, Sarah S Richardson, Katharine M N Lee
{"title":"Exploring the Contributions of Gendered Social Factors to Sex Disparities in Adverse Drug Events.","authors":"Annika Gompers, Tamara Rushovich, Sarah S Richardson, Katharine M N Lee","doi":"10.1016/j.whi.2025.12.003","DOIUrl":"https://doi.org/10.1016/j.whi.2025.12.003","url":null,"abstract":"","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Women's Perspectives on the Influence of Intimate Partner Violence on Substance Use Disorder Recovery and Associated Service Needs 妇女对亲密伴侣暴力对物质使用障碍康复和相关服务需求影响的看法。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2025-11-10 DOI: 10.1016/j.whi.2025.10.004
Shannon N. Ogden PhD, MPH , Melissa E. Dichter PhD, MSW , Erin Major BA , Miriam T.H. Harris MD, MSc , Danielle F. Haley PhD, MPH , Paul R. Shafer PhD , Jack A. Clark PhD

Background

Intimate partner violence (IPV) is a prevalent source of stress and trauma among women, especially among women who use substances. However, IPV-related trauma is not widely addressed in substance use disorder (SUD) treatment and research on the influence of IPV on SUD is limited. We aimed to explore women's perspectives on the impacts of IPV on their substance use and recovery and identify associated service needs.

Methods

We conducted semi-structured interviews with women who experienced IPV and received SUD treatment at a safety-net health system in Massachusetts (June–October 2023). Pre-interview questionnaires captured demographic characteristics and histories of IPV, substance use, and receipt of SUD services. Interviews were audio-recorded, transcribed, and thematically analyzed using content analysis with an iterative inductive and deductive team-based analytic process.

Results

Twelve participants who identified as non-Hispanic Black (n = 2), non-Hispanic white (n = 7), Hispanic (n = 2), and more than one race (n = 1) completed interviews. All participants had experienced substance use and IPV. We identified three themes related to the perceived impact of IPV on substance use recovery and service access: 1) partner's coercive and controlling behaviors can contribute to women's substance use and inhibit SUD service engagement, 2) mental health impacts of IPV can exacerbate substance use and inhibit engagement in SUD services, and 3) women value mental health and IPV supportive services, along with SUD treatment, for their recovery.

Conclusion

Our findings highlight the need for co-addressing mental health and IPV concerns with SUD treatment to support women's recovery, including increased mental health and peer support to complement SUD treatment. Implementing a trauma-informed approach in SUD treatment could help address the underlying sources of stress and trauma among women to improve SUD treatment outcomes and overall well-being.
背景:亲密伴侣暴力(IPV)是妇女压力和创伤的普遍来源,特别是在使用药物的妇女中。然而,IPV相关创伤在物质使用障碍(SUD)治疗中并未得到广泛关注,IPV对SUD影响的研究也很有限。我们的目的是探讨妇女对IPV对其药物使用和恢复的影响的看法,并确定相关的服务需求。方法:我们对在马萨诸塞州安全网卫生系统(2023年6月至10月)经历IPV并接受SUD治疗的妇女进行了半结构化访谈。访谈前的问卷收集了IPV的人口统计学特征和历史、药物使用和SUD服务的接受情况。访谈录音,转录,并使用内容分析与迭代归纳和演绎团队为基础的分析过程进行主题分析。结果:12名被确定为非西班牙裔黑人(n = 2)、非西班牙裔白人(n = 7)、西班牙裔(n = 2)和不止一个种族(n = 1)的参与者完成了访谈。所有参与者都经历过药物使用和IPV。我们确定了与IPV对物质使用恢复和服务获取的感知影响相关的三个主题:1)伴侣的强迫和控制行为可以促进女性的物质使用并抑制SUD服务的参与;2)IPV的心理健康影响可以加剧物质使用并抑制SUD服务的参与;3)女性重视心理健康和IPV支持服务,以及SUD治疗,以帮助她们恢复。结论:我们的研究结果强调,需要在SUD治疗中共同解决心理健康和IPV问题,以支持女性康复,包括增加心理健康和同伴支持,以补充SUD治疗。在SUD治疗中实施创伤知情方法可以帮助解决女性压力和创伤的潜在来源,以改善SUD治疗效果和整体幸福感。
{"title":"Women's Perspectives on the Influence of Intimate Partner Violence on Substance Use Disorder Recovery and Associated Service Needs","authors":"Shannon N. Ogden PhD, MPH ,&nbsp;Melissa E. Dichter PhD, MSW ,&nbsp;Erin Major BA ,&nbsp;Miriam T.H. Harris MD, MSc ,&nbsp;Danielle F. Haley PhD, MPH ,&nbsp;Paul R. Shafer PhD ,&nbsp;Jack A. Clark PhD","doi":"10.1016/j.whi.2025.10.004","DOIUrl":"10.1016/j.whi.2025.10.004","url":null,"abstract":"<div><h3>Background</h3><div>Intimate partner violence (IPV) is a prevalent source of stress and trauma among women, especially among women who use substances. However, IPV-related trauma is not widely addressed in substance use disorder (SUD) treatment and research on the influence of IPV on SUD is limited. We aimed to explore women's perspectives on the impacts of IPV on their substance use and recovery and identify associated service needs.</div></div><div><h3>Methods</h3><div>We conducted semi-structured interviews with women who experienced IPV and received SUD treatment at a safety-net health system in Massachusetts (June–October 2023). Pre-interview questionnaires captured demographic characteristics and histories of IPV, substance use, and receipt of SUD services. Interviews were audio-recorded, transcribed, and thematically analyzed using content analysis with an iterative inductive and deductive team-based analytic process.</div></div><div><h3>Results</h3><div>Twelve participants who identified as non-Hispanic Black (<em>n</em> = 2), non-Hispanic white (<em>n</em> = 7), Hispanic (<em>n</em> = 2), and more than one race (<em>n</em> = 1) completed interviews. All participants had experienced substance use and IPV. We identified three themes related to the perceived impact of IPV on substance use recovery and service access: 1) partner's coercive and controlling behaviors can contribute to women's substance use and inhibit SUD service engagement, 2) mental health impacts of IPV can exacerbate substance use and inhibit engagement in SUD services, and 3) women value mental health and IPV supportive services, along with SUD treatment, for their recovery.</div></div><div><h3>Conclusion</h3><div>Our findings highlight the need for co-addressing mental health and IPV concerns with SUD treatment to support women's recovery, including increased mental health and peer support to complement SUD treatment. Implementing a trauma-informed approach in SUD treatment could help address the underlying sources of stress and trauma among women to improve SUD treatment outcomes and overall well-being.</div></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 70-78"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Prevalence of Polycystic Ovary Syndrome in United States Military Active-Duty Service Members 多囊卵巢综合征在美国现役军人中的发病率和患病率。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2025-11-01 DOI: 10.1016/j.whi.2025.09.004
Mary Swinton DO , Michael Kim MD, FAAFP , David A. Klein MD, MPH , Jennifer A. Thornton PhD , Kevin W. Sunderland PhD , Rick Brydum BS , Wendy Funk MS , Veronika Pav MS , Megan N. Parker PhD

Background

Polycystic ovary syndrome (PCOS) is a chronic medical condition characterized by ovulatory dysfunction, hyperandrogenism, and/or polycystic ovary morphology. Data on rates of PCOS among active-duty service members (ADSMs) are limited, despite high risk for medical comorbidities (e.g., obesity, type 2 diabetes) that could negatively impact ADSMs’ health and military careers. This study aimed to describe the incidence and prevalence of PCOS and possible PCOS (i.e., both ovulatory dysfunction and hyperandrogenism) among ADSMs.

Methods

This retrospective cohort study accessed data from the Military Health System Data Repository between 2018 and 2022. ADSMs with a PCOS International Classification of Diseases, 10th Revision (ICD-10) code or ICD-10 codes indicative of irregular menstruation and hyperandrogenism within a 12-month period (i.e., possible PCOS) were identified. The yearly incidence and prevalence of PCOS/possible PCOS were computed per 10,000 female ADSMs, and Jonckheere-Terpstra tests for trend(s) were conducted.

Results

During the surveillance period, 15,059 ADSMs met the criteria for PCOS or possible PCOS (55% white, 16% Hispanic/Latina; 44% aged 22–27 years; 85% enlisted, 13% officers). The yearly incidence rate of PCOS/possible PCOS ranged from 73 per 10,000 female ADSMs in 2018 to 103 per 10,000 female ADSMs in 2022 and did not change significantly (p = .33). The prevalence of PCOS/possible PCOS increased significantly (p = .01) from 210 per 10,000 female ADSMs in 2018 to 380 per 10,000 female ADSMs in 2022.

Conclusion

Approximately 4% of ADSMs had a diagnosis of PCOS during the 5-year surveillance period, and about 1% of ADSMs newly met criteria for PCOS each year. More research is needed to determine the health care needs of ADSMs with PCOS.
背景:多囊卵巢综合征(PCOS)是一种以排卵功能障碍、雄激素分泌过多和/或多囊卵巢形态为特征的慢性疾病。尽管可能对现役军人的健康和军事生涯产生负面影响的医疗合并症(如肥胖、2型糖尿病)的风险很高,但有关现役军人多囊性卵巢综合征发病率的数据有限。本研究旨在描述adsm中多囊卵巢综合征(PCOS)和可能的多囊卵巢综合征(即排卵功能障碍和高雄激素症)的发病率和患病率。方法:本回顾性队列研究访问了2018 - 2022年军队卫生系统数据库的数据。adsm具有PCOS国际疾病分类第十版(ICD-10)代码或ICD-10代码,表明12个月内月经不调和雄激素过多(即可能的PCOS)。计算每10,000名adsm女性PCOS/可能PCOS的年发病率和患病率,并进行Jonckheere-Terpstra趋势测试。结果:在监测期间,15,059名adsm符合PCOS或可能的PCOS标准(55%为白人,16%为西班牙裔/拉丁裔,44%为22-27岁,85%为现役,13%为军官)。PCOS/可能PCOS的年发病率从2018年的73 / 10,000女性adsm到2022年的103 / 10,000女性adsm没有显著变化(p = 0.33)。多囊卵巢综合征/可能多囊卵巢综合征的患病率显著增加(p = 0.01),从2018年的210 / 10,000女性adsm增加到2022年的380 / 10,000女性adsm。结论:在5年的监测期间,约有4%的adsm被诊断为PCOS,每年约有1%的adsm新达到PCOS标准。需要更多的研究来确定adsm与PCOS的医疗保健需求。
{"title":"Incidence and Prevalence of Polycystic Ovary Syndrome in United States Military Active-Duty Service Members","authors":"Mary Swinton DO ,&nbsp;Michael Kim MD, FAAFP ,&nbsp;David A. Klein MD, MPH ,&nbsp;Jennifer A. Thornton PhD ,&nbsp;Kevin W. Sunderland PhD ,&nbsp;Rick Brydum BS ,&nbsp;Wendy Funk MS ,&nbsp;Veronika Pav MS ,&nbsp;Megan N. Parker PhD","doi":"10.1016/j.whi.2025.09.004","DOIUrl":"10.1016/j.whi.2025.09.004","url":null,"abstract":"<div><h3>Background</h3><div>Polycystic ovary syndrome (PCOS) is a chronic medical condition characterized by ovulatory dysfunction, hyperandrogenism, and/or polycystic ovary morphology. Data on rates of PCOS among active-duty service members (ADSMs) are limited, despite high risk for medical comorbidities (e.g., obesity, type 2 diabetes) that could negatively impact ADSMs’ health and military careers. This study aimed to describe the incidence and prevalence of PCOS and possible PCOS (i.e., both ovulatory dysfunction and hyperandrogenism) among ADSMs.</div></div><div><h3>Methods</h3><div>This retrospective cohort study accessed data from the Military Health System Data Repository between 2018 and 2022. ADSMs with a PCOS International Classification of Diseases, 10<sup>th</sup> Revision (ICD-10) code or ICD-10 codes indicative of irregular menstruation and hyperandrogenism within a 12-month period (i.e., possible PCOS) were identified. The yearly incidence and prevalence of PCOS/possible PCOS were computed per 10,000 female ADSMs, and Jonckheere-Terpstra tests for trend(s) were conducted.</div></div><div><h3>Results</h3><div>During the surveillance period, 15,059 ADSMs met the criteria for PCOS or possible PCOS (55% white, 16% Hispanic/Latina; 44% aged 22–27 years; 85% enlisted, 13% officers). The yearly incidence rate of PCOS/possible PCOS ranged from 73 per 10,000 female ADSMs in 2018 to 103 per 10,000 female ADSMs in 2022 and did not change significantly (<em>p</em> = .33). The prevalence of PCOS/possible PCOS increased significantly (<em>p</em> = .01) from 210 per 10,000 female ADSMs in 2018 to 380 per 10,000 female ADSMs in 2022.</div></div><div><h3>Conclusion</h3><div>Approximately 4% of ADSMs had a diagnosis of PCOS during the 5-year surveillance period, and about 1% of ADSMs newly met criteria for PCOS each year. More research is needed to determine the health care needs of ADSMs with PCOS.</div></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 79-88"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in Preterm Births by State Reproductive Rights Policy Environment: Findings From the 2022 National Vital Statistics Birth Data 国家生育权政策环境对早产儿的差异——来自2022年全国人口生命统计出生数据的发现
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2025-11-17 DOI: 10.1016/j.whi.2025.10.007
Simrun Varshney MPH , Emily Lauren Lam BA , Madeline Perry MD , Christina Kim MD, MPH , Joe Feinglass PhD

Objectives

This study analyzed the extent to which variations in state preterm birth rates are associated with state reproductive rights policies after accounting for individual risk factors.

Methods

The study analyzed preterm (<37 weeks) births using the 2022 National Vital Statistics System Natality File. State reproductive rights policy scores were obtained from the Institute for Women's Policy Research (IWPR) 2022 Reproductive Rights Index. IWPR scores were trichotomized to reflect approximately one-third of births occurring in most-restrictive, somewhat-restrictive, and least-restrictive states. Logistic regression was used to estimate the likelihood of preterm birth, testing the independent significance of state reproductive rights restrictions after adjusting for maternal characteristics. Sensitivity analyses adjusted for other state characteristics.

Results

Among 3,530,543 births analyzed, mean preterm birth rates ranged from a mean of 9.4% in the group of the least-restrictive states to a mean of 11.2% in the group of most-restrictive states. The highest rates were in Mississippi (14.3%), Louisiana (13.3%), and West Virginia (13.3%), all in the most-restrictive category. There was an r = .54 correlation between state IWPR scores and preterm birth percentage (p < .001). After adjusting for sociodemographic and clinical risk factors, births in the most-restrictive states had 20% higher and somewhat-restrictive states had 16% higher odds of preterm birth as compared with births in the least-restrictive states, with state rankings attenuated but remaining significant after inclusion of other state characteristics.

Conclusion

Although this study cannot establish causal inference, restrictive reproductive rights may be linked to prematurity through higher rates of unintended pregnancy and greater maternal comorbidity. Study findings add to a growing literature on health status differences between states associated with restrictive reproductive rights legislation.
目的:本研究在考虑了个体风险因素后,分析了各州早产率变化与各州生殖权利政策的关联程度。方法:该研究分析了早产(结果:在分析的3,530,543例新生儿中,限制最少的州的平均早产率为9.4%,限制最多的州的平均早产率为11.2%)。比例最高的是密西西比州(14.3%)、路易斯安那州(13.3%)和西弗吉尼亚州(13.3%),这些州都属于限制最严格的类别。州IWPR评分与早产率的相关性为r = 0.54 (p < 0.001)。在调整了社会人口统计学和临床风险因素后,与限制最少的州相比,限制最多的州的早产几率高出20%,而限制程度较低的州的早产几率高出16%,各州的排名有所下降,但在纳入其他州的特征后仍然显著。结论:虽然本研究不能建立因果推理,但限制性生殖权利可能通过较高的意外怀孕率和更大的孕产妇合并症与早产有关。研究结果为越来越多的关于各州与限制性生殖权利立法相关的健康状况差异的文献提供了补充。
{"title":"Differences in Preterm Births by State Reproductive Rights Policy Environment: Findings From the 2022 National Vital Statistics Birth Data","authors":"Simrun Varshney MPH ,&nbsp;Emily Lauren Lam BA ,&nbsp;Madeline Perry MD ,&nbsp;Christina Kim MD, MPH ,&nbsp;Joe Feinglass PhD","doi":"10.1016/j.whi.2025.10.007","DOIUrl":"10.1016/j.whi.2025.10.007","url":null,"abstract":"<div><h3>Objectives</h3><div>This study analyzed the extent to which variations in state preterm birth rates are associated with state reproductive rights policies after accounting for individual risk factors.</div></div><div><h3>Methods</h3><div>The study analyzed preterm (&lt;37 weeks) births using the 2022 National Vital Statistics System Natality File. State reproductive rights policy scores were obtained from the Institute for Women's Policy Research (IWPR) 2022 Reproductive Rights Index. IWPR scores were trichotomized to reflect approximately one-third of births occurring in most-restrictive, somewhat-restrictive, and least-restrictive states. Logistic regression was used to estimate the likelihood of preterm birth, testing the independent significance of state reproductive rights restrictions after adjusting for maternal characteristics. Sensitivity analyses adjusted for other state characteristics.</div></div><div><h3>Results</h3><div>Among 3,530,543 births analyzed, mean preterm birth rates ranged from a mean of 9.4% in the group of the least-restrictive states to a mean of 11.2% in the group of most-restrictive states. The highest rates were in Mississippi (14.3%), Louisiana (13.3%), and West Virginia (13.3%), all in the most-restrictive category. There was an r = .54 correlation between state IWPR scores and preterm birth percentage (<em>p</em> &lt; .001). After adjusting for sociodemographic and clinical risk factors, births in the most-restrictive states had 20% higher and somewhat-restrictive states had 16% higher odds of preterm birth as compared with births in the least-restrictive states, with state rankings attenuated but remaining significant after inclusion of other state characteristics.</div></div><div><h3>Conclusion</h3><div>Although this study cannot establish causal inference, restrictive reproductive rights may be linked to prematurity through higher rates of unintended pregnancy and greater maternal comorbidity. Study findings add to a growing literature on health status differences between states associated with restrictive reproductive rights legislation.</div></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 11-19"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gibbs Leadership Prize: Best Paper of 2025 in Women's Health Issues 吉布斯领导奖:2025年妇女健康问题最佳论文
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2026-02-03 DOI: 10.1016/j.whi.2026.01.001
{"title":"Gibbs Leadership Prize: Best Paper of 2025 in Women's Health Issues","authors":"","doi":"10.1016/j.whi.2026.01.001","DOIUrl":"10.1016/j.whi.2026.01.001","url":null,"abstract":"","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 1-2"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146098705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Menstrual Equity Behind Bars: A Call for National Policy Reform 监狱里的月经平等:呼吁国家政策改革。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2025-12-19 DOI: 10.1016/j.whi.2025.11.001
Anisha V. Patel BA , Sahara Suliman , Ankita Patil BA, MS , Harini Thiruvengadam , Ran Zhang PhD
{"title":"Menstrual Equity Behind Bars: A Call for National Policy Reform","authors":"Anisha V. Patel BA ,&nbsp;Sahara Suliman ,&nbsp;Ankita Patil BA, MS ,&nbsp;Harini Thiruvengadam ,&nbsp;Ran Zhang PhD","doi":"10.1016/j.whi.2025.11.001","DOIUrl":"10.1016/j.whi.2025.11.001","url":null,"abstract":"","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 8-10"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provider Perspectives on De-Implementation of Routine Blood Typing and Rh Immune Globulin Administration in the First Trimester: A Qualitative Study 提供者对在妊娠早期取消常规血型和Rh免疫球蛋白管理的观点:一项定性研究。
IF 2.5 2区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-01-01 Epub Date: 2025-11-10 DOI: 10.1016/j.whi.2025.10.001
Emma V. Gilmore MD, Madeline V. Smith MPH, Cecelia Tannous-Taylor BA, Arden McAllister MPH, Courtney A. Schreiber MD, MPH, Sarita Sonalkar MD, MPH

Objective

To avoid the consequences of sensitization that can occur when people with Rh-negative blood are pregnant with Rh-positive fetuses and experience bleeding, obstetrician-gynecologists have historically administered prophylactic Rh immune globulin for any first trimester bleeding, including abortion and pregnancy loss. As the research base has evolved, many professional societies have changed their recommendations on the use of blood typing and Rh immune globulin administration for first trimester bleeding, but widespread practice has yet to change. We aimed to understand barriers to de-implementation of routine testing and prophylaxis for first trimester bleeding events from the perspective of obstetrician-gynecologist physicians.

Study Design

We conducted qualitative in-depth interviews with obstetrician-gynecologists who provide first trimester pregnancy care. Guided by the Integrated Behavior Model and the Consolidated Framework for Implementation Research, we elicited participants’ perceived barriers to de-implementation of routine Rh testing and Rh immune globulin prophylaxis for first trimester bleeding and suggestions for de-implementation strategies. Data were coded iteratively and analyzed thematically.

Results

Twenty physicians completed interviews. Participants were based in 11 states and worked in settings that included teaching hospitals, freestanding abortion clinics, private practices, and the carceral system. Barriers to de-implementation included a lack of familiarity with evidence and limited time to engage in change initiatives. Although society guidance change was considered an essential component in discontinuing this longstanding practice, other drivers of practice change were reported to be additional studies on Rh sensitization in the first trimester, leadership support, and educational initiatives for providers and patients.

Conclusions

Obstetrician-gynecologists in this study favored de-implementation of routine blood typing and Rh immune globulin prophylaxis in first trimester bleeding but lacked sufficient support. Practice change becomes more likely when providers feel confident in their grasp of evidence, institutional leaders support change, and relevant professional societies are aligned in their guidance.
目的:为避免Rh阴性血孕妇与Rh阳性胎儿出血时可能发生的致敏后果,妇产科医生历来对任何妊娠早期出血(包括流产和流产)给予预防性Rh免疫球蛋白。随着研究基础的发展,许多专业协会已经改变了他们对使用血型和Rh免疫球蛋白治疗妊娠早期出血的建议,但广泛的做法尚未改变。我们的目的是从妇产科医生的角度了解取消常规检查和预防妊娠早期出血事件的障碍。研究设计:我们对提供妊娠早期护理的妇产科医生进行了定性深入访谈。在综合行为模型和实施研究综合框架的指导下,我们得出了参与者对取消常规Rh检测和Rh免疫球蛋白预防妊娠早期出血的障碍以及取消实施策略的建议。对数据进行迭代编码和主题分析。结果:20名医生完成访谈。参与者来自11个州,在教学医院、独立堕胎诊所、私人诊所和医疗系统等环境中工作。去实施的障碍包括缺乏对证据的熟悉,以及参与变革倡议的时间有限。虽然社会指导的改变被认为是终止这种长期做法的重要组成部分,但据报道,其他推动实践变化的因素包括妊娠早期Rh致敏的额外研究、领导支持以及对提供者和患者的教育举措。结论:在这项研究中,妇产科医生倾向于在妊娠早期出血时取消常规血型和Rh免疫球蛋白预防,但缺乏足够的支持。当提供者对他们掌握的证据有信心,机构领导人支持变革,以及相关专业协会在他们的指导下保持一致时,实践变革就更有可能发生。
{"title":"Provider Perspectives on De-Implementation of Routine Blood Typing and Rh Immune Globulin Administration in the First Trimester: A Qualitative Study","authors":"Emma V. Gilmore MD,&nbsp;Madeline V. Smith MPH,&nbsp;Cecelia Tannous-Taylor BA,&nbsp;Arden McAllister MPH,&nbsp;Courtney A. Schreiber MD, MPH,&nbsp;Sarita Sonalkar MD, MPH","doi":"10.1016/j.whi.2025.10.001","DOIUrl":"10.1016/j.whi.2025.10.001","url":null,"abstract":"<div><h3>Objective</h3><div>To avoid the consequences of sensitization that can occur when people with Rh-negative blood are pregnant with Rh-positive fetuses and experience bleeding, obstetrician-gynecologists have historically administered prophylactic Rh immune globulin for any first trimester bleeding, including abortion and pregnancy loss. As the research base has evolved, many professional societies have changed their recommendations on the use of blood typing and Rh immune globulin administration for first trimester bleeding, but widespread practice has yet to change. We aimed to understand barriers to de-implementation of routine testing and prophylaxis for first trimester bleeding events from the perspective of obstetrician-gynecologist physicians.</div></div><div><h3>Study Design</h3><div>We conducted qualitative in-depth interviews with obstetrician-gynecologists who provide first trimester pregnancy care. Guided by the Integrated Behavior Model and the Consolidated Framework for Implementation Research, we elicited participants’ perceived barriers to de-implementation of routine Rh testing and Rh immune globulin prophylaxis for first trimester bleeding and suggestions for de-implementation strategies. Data were coded iteratively and analyzed thematically.</div></div><div><h3>Results</h3><div>Twenty physicians completed interviews. Participants were based in 11 states and worked in settings that included teaching hospitals, freestanding abortion clinics, private practices, and the carceral system. Barriers to de-implementation included a lack of familiarity with evidence and limited time to engage in change initiatives. Although society guidance change was considered an essential component in discontinuing this longstanding practice, other drivers of practice change were reported to be additional studies on Rh sensitization in the first trimester, leadership support, and educational initiatives for providers and patients.</div></div><div><h3>Conclusions</h3><div>Obstetrician-gynecologists in this study favored de-implementation of routine blood typing and Rh immune globulin prophylaxis in first trimester bleeding but lacked sufficient support. Practice change becomes more likely when providers feel confident in their grasp of evidence, institutional leaders support change, and relevant professional societies are aligned in their guidance.</div></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":"36 1","pages":"Pages 45-51"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Womens Health Issues
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1